Flunarizine Tablet Dealers in Mumbai

• Brand Name: Fludix
• Form: Tablets
• Packaging Type: Blister
• Packaging Size: 20×10 tablets
• Medicine Type: Allopathic
• Treatment: Used to treat states of the stomach, throat, and digestive organs
• Composition: Flunarizine Dihydrochloride
• Manufactured By: Psychocare Health Pvt Ltd

• Form: Tablets
• Packaging Type: Plastic Bottle
• Packaging Size: 25 Tablets
• Medicine Type: Allopathic
• Treatment: Used to Treat a Certain Type of Cancer (Acute Myeloid Leukemia-AML)
• Composition: Thioguanine 40mg
• Manufactured By: Naprod Life Sciences Pvt. Ltd.

• Supplied By: UMA Brothers, India

We are offering flunarizine dihydrochloride. Flunarizine dihydrochloride is a drug classified as a calcium channel blocker. Flunarizine is a non-selective calcium entry blocker with other actions including histamine h1 receptor blocking activity. It is effective in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy. It may help to reduce the severity and duration of attacks of paralysis associated with the more serious form of alternating hemiplegia, as well as being effective in rapid onset dystonia-parkinsonism (rdp). synonyms: 1-[bis (4-fluorophenyl) methyl]-4-[(e)-3-phenylprop-2-enyl] piperazine; dihydrochloride cas number: 30484-77-6, mol. Formula: c26h28cl2f2n2, mol.weight: 477.42 flunarizine dihydrochloride is white solid powder. It is soluble in dmso (25mgml), 100% ehanol (5mgml) or chloroform: methanol (1:1; 50mgml) with melting range of 188°c to 190°c. Standard: offered of pharmaceutical grade bpuspep packing: offered in export worthy packing of 25 kilos or as per our customer requirements

• WHITE SOLID POWDER: WHITE SOLID POWDER

Flunarizine dihydrochloride is a drug classified as a calcium channel blocker. Flunarizine is a non-selective calcium entry blocker with other actions including histamine h1 receptor blocking activity. It is effective in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy. It may help to reduce the severity and duration of attacks of paralysis associated with the more serious form of alternating hemiplegia, as well as being effective in rapid onset dystonia-parkinsonism (rdp).